Loading...
10 South Korea Diabetes Care Drugs Reports
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
Country Covered: South Korea
Study Period: 2021- 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis
Country Covered: South Korea
Study Period: 2018 - 2029
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Vivus, F Hoffmann-La Roche AG, GlaxoSmithKline PLC, Novo Nordisk AS, Currax Pharmaceuticals LLC
Country Covered: South Korea
Study Period: 2018 - 2029
Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca
Country Covered: South Korea
Study Period: 2019- 2029
Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Novartis AG, Regeneron Pharmaceuticals Inc, Allergan Plc, Hoffmann-La Roche (Genentech), Oxurion NV
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Merck & Co., Inc, Sanofi, Amgen, AstraZeneca, Viatris Inc.
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: Convatec Inc., 3M, Integra LifeSciences, Coloplast Corp, Cardinal Health
